{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T17:01:19Z","timestamp":1790269279496,"version":"4.1.0"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2003,3,7]],"date-time":"2003-03-07T00:00:00Z","timestamp":1046995200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Rheumatol Int"],"published-print":{"date-parts":[[2003,5]]},"DOI":"10.1007\/s00296-002-0267-y","type":"journal-article","created":{"date-parts":[[2018,12,17]],"date-time":"2018-12-17T20:11:23Z","timestamp":1545077483000},"page":"134-137","source":"Crossref","is-referenced-by-count":34,"title":["Methotrexate inhibits interleukin-6 production in patients with juvenile rheumatoid arthritis"],"prefix":"10.1007","volume":"23","author":[{"given":"Amita","family":"Aggarwal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramnath","family":"Misra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2003,3,7]]},"reference":[{"key":"0267_CR1","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1056\/NEJM199204163261602","volume":"326","author":"Ginnani","year":"1992","unstructured":"Ginnani EH, Brewer EJ, Kuzima N, Shakiov A, Maximov A, Vorontsov I, Fink CW, Newman AJ, Cassidy JT, Zemel LS (1992) Methotrexate in resistant juvenile rheumatoid arthritis. Results of the USA-USSR double blind placebo controlled trial. The Pediatric Rheumatology Collaborative Study Group and The Cooperative Study Group. N Engl J Med 326:1043\u20131049","journal-title":"N Engl J Med"},{"key":"0267_CR2","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1097\/00002281-199905000-00012","volume":"11","author":"Seitz","year":"1999","unstructured":"Seitz M (1999) Molecular and cellular effects of methotrexate. Curr Opin Rheumatol 11:226\u2013232","journal-title":"Curr Opin Rheumatol"},{"key":"0267_CR3","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/S0889-857X(05)70358-6","volume":"23","author":"Cornstein","year":"1997","unstructured":"Cornstein BN (1997) The mechanism of action of methotrexate. Rheum Dis Clin North Am 23:739\u2013755","journal-title":"Rheum Dis Clin North Am"},{"key":"0267_CR4","first-page":"1678","volume":"19","author":"Chang","year":"1992","unstructured":"Chang DM, Weinblatt ME, Schur PH (1992) The effects of methotrexate on interleukin 1 in patients with rheumatoid arthritis. J Rheumatol 19:1678\u20131682","journal-title":"J Rheumatol"},{"key":"0267_CR5","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1002\/1529-0131(199811)41:11<2032::AID-ART19>3.0.CO;2-J","volume":"41","author":"Seitz","year":"1998","unstructured":"Seitz M, Zwicker M, Loetscher P (1998) Effect of methotrexate on differentiation of monocytes and production of cytokine inhibitors by monocytes. Arthritis Rheum 41:2032\u20132038","journal-title":"Arthritis Rheum"},{"key":"0267_CR6","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1111\/j.1365-2362.1994.tb02063.x","volume":"24","author":"Wascher","year":"1994","unstructured":"Wascher TC, Hermann J, Brezineschek R et al (1994) Serum levels of interleukin-6 and tumor necrosis factor alpha are not correlated to disease activity in patients with rheumatoid arthritis after treatment with low dose methotrexate. Eur J Clin Invest 24:73\u201375","journal-title":"Eur J Clin Invest"},{"key":"0267_CR7","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1002\/art.1780360807","volume":"36","author":"Barrera","year":"1993","unstructured":"Barrera P, Boerbooms AMT, Janssen EM et al (1993) Circulating soluble tumor necrosis factor receptors, interleukin-2 receptors, tumor necrosis factor alpha and interleukin-6 levels in rheumatoid arthritis: longitudinal evaluation during methotrexate and azathioprine therapy. Arthritis Rheum 36:1070\u20131079","journal-title":"Arthritis Rheum"},{"key":"0267_CR8","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1002\/art.1780290216","volume":"29","author":"Cassidy","year":"1986","unstructured":"Cassidy JT, Levinson JE, Bass JC, Baum J, Brewer EJ Jr, Fink CW, Hanson V, Jacobs JC, Masi AT, Schaller JG, Fries JF, McShane D, Young D (1986) A study of classification criteria for the diagnosis of juvenile rheumatoid arthritis. Arthritis Rheum 29:274\u2013281","journal-title":"Arthritis Rheum"},{"key":"0267_CR9","first-page":"224","volume":"22","author":"Crilly","year":"1995","unstructured":"Crilly A, McIness JB, McDonald AG et al (1995) Interleukin-6 (IL-6) and IL-2 receptor levels in patients with rheumatoid arthritis patients treated with low dose oral methotrexate. J Rheumatol 22:224\u2013226","journal-title":"J Rheumatol"},{"key":"0267_CR10","unstructured":"Seitz M, Dayer JM (1998) Stimulation of TIMP-1 production in rheumatoid arthritis upon MTX treatment. Z Rheumatol 57 [Suppl\u00a01]:122"},{"key":"0267_CR11","first-page":"1512","volume":"23","author":"Seitz","year":"1996","unstructured":"Seitz M, Loetscher P, Dewald B et al (1996) Interleukin 1 (IL-1) receptor antagonist, soluble tumor necrosis factor receptors, IL-1 beta and IL-8\u2014markers of remission in rheumatoid arthritis during treatment with methotrexate. J Rheumatol 23:1512\u20131516","journal-title":"J Rheumatol"},{"key":"0267_CR12","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1093\/rheumatology\/34.8.747","volume":"34","author":"Barrera","year":"1995","unstructured":"Barrera P, Haagsma CJ, Boerbooms AMT, Van Riel PLCM, Borm GF, Van De Putte LBA, Van Der Meer JWM (1995) Effect of methotrexate alone or in combination with sulphasalazine, on the production and circulating concentrations of cytokines and their antagonists. Longitudinal evaluation in patients with rheumatoid arthritis. Br J Rheumatol 34:747\u2013755","journal-title":"Br J Rheumatol"},{"key":"0267_CR13","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1093\/rheumatology\/34.3.241","volume":"34","author":"Willam","year":"1995","unstructured":"Willam AS, Punn YL,Amos N et al (1995) The effect of liposomally conjugated methotrexate upon mediator release from human peripheral blood monocytes. Br J Rheumatol 34:241\u2013245","journal-title":"Br J Rheumatol"},{"key":"0267_CR14","doi-asserted-by":"crossref","first-page":"3435","DOI":"10.4049\/jimmunol.156.9.3435","volume":"56","author":"Sajjadi","year":"1996","unstructured":"Sajjadi FG, Takabayashi K, Foster AC, Domingo RC, Firestein GS (1996) Inhibition of TNF-alpha expression by adenosine: role of A3 receptors. J Immunol 56:3435\u2013342","journal-title":"J Immunol"},{"key":"0267_CR15","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1046\/j.1365-2249.1999.01022.x","volume":"118","author":"Hildner","year":"1999","unstructured":"Hildner K, Finotto S, Becker C, Schlaak J, Schirmacher P, Galle PR, Marker-Hermann E, Neurath MF (1999) Tumour necrosis factor (TNF) production by T cell receptor-primed T lymphocytes is a target for low dose methotrexate in rheumatoid arthritis. Clin Exp Immunol 118:137\u2013146","journal-title":"Clin Exp Immunol"}],"container-title":["Rheumatology International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-002-0267-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00296-002-0267-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-002-0267-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,12]],"date-time":"2023-09-12T07:03:34Z","timestamp":1694502214000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00296-002-0267-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,3,7]]},"references-count":15,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2003,5]]}},"alternative-id":["0267"],"URL":"https:\/\/doi.org\/10.1007\/s00296-002-0267-y","relation":{},"ISSN":["0172-8172","1437-160X"],"issn-type":[{"value":"0172-8172","type":"print"},{"value":"1437-160X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,3,7]]}}}